Bliss Kelly 4

What Happened
Bliss Kelly, President, U.S. Group Health at Teladoc Health, reported a sale of 2,500 shares (transaction code S) on July 1, 2026 at $9.00 per share, for total proceeds of $22,500. This was a disposal (sale), which is often routine for insiders but provides less direct indication of future company performance than purchases.

Key Details

• Transaction date and price: 2026-07-01 — 2,500 shares at $9.00 each.
• Total value: $22,500.
• Transaction type: Sale (reported as "open market or private sale" — code S).
• Footnote: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025.
• Filing timeliness: Report filed on 2026-07-01 (same day as the reported transaction date in this filing excerpt).
• Shares owned after transaction: Not disclosed in the provided filing excerpt.

Context
The sale was executed under a pre-arranged 10b5-1 plan, which allows insiders to sell shares according to a predetermined schedule and can reduce the likelihood the sale reflects a contemporaneous private view. As a sale, it is typically viewed as routine insider liquidity rather than a clear bullish signal; purchases generally carry more weight for signaling insider confidence.